Symbol="CLDX"
AssetType="Common Stock"
Name="Celldex Therapeutics Inc"
Description="Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. The company is headquartered in Hampton, New Jersey."
CIK="744218"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1676046000"
EBITDA="-112963000"
PERatio="None"
PEGRatio="0"
BookValue="6.41"
DividendPerShare="0"
DividendYield="0"
EPS="-2.54"
RevenuePerShareTTM="0.067"
ProfitMargin="0"
OperatingMarginTTM="-36.75"
ReturnOnAssetsTTM="-0.193"
ReturnOnEquityTTM="-0.339"
RevenueTTM="3150000"
GrossProfitTTM="-79901000"
DilutedEPSTTM="-2.54"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.557"
AnalystTargetPrice="66.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1935.11"
PriceToBookRatio="5.07"
EVToRevenue="1326.45"
EVToEBITDA="-16.28"
Beta="2.112"
num_52WeekHigh="48.4"
num_52WeekLow="24.58"
num_50DayMovingAverage="33.84"
num_200DayMovingAverage="37.03"
SharesOutstanding="47252500"
DividendDate="2019-02-11"
ExDividendDate="None"
symbol="CLDX"
open="34.98"
high="35.73"
low="34.24"
price="35.47"
volume="255223.00"
latest_trading_day="2023-07-06"
previous_close="35.17"
change="0.30"
change_percent="0.8530%"
aroon_positive_momentum_days="35"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="35"
Volume_recent_avg="579316"
Change_recent_avg="-0.04"
Delta_recent_avg="1.65"
Variance_recent_avg="0.83"
Change_ratio_recent_avg="-0.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="35"
Aroon_momentum_negative="65"
image_negative_thumbnail_id_1="121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_negative_thumbnail_id_2="1159"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0193.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="674"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_positive_thumbnail_id_2="968"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
